ArticleDeciphering Deazapurine Biosynthesis: Pathway for Pyrrolopyrimidine Nucleosides Toyocamycin and SANGIVAMYCIN (cas 18417-89-5)
-
Add time:08/31/2019 Source:sciencedirect.com
SummaryPyrrolopyrimidine nucleosides analogs, collectively referred to as deazapurines, are an important class of structurally diverse compounds found in a wide variety of biological niches. In this report, a cluster of genes from Streptomyces rimosus (ATCC 14673) involved in production of the deazapurine antibiotics sangivamycin and toyocamycin was identified. The cluster includes toyocamycin nitrile hydratase, an enzyme that catalyzes the conversion of toyocamycin to sangivamycin. In addition to this rare nitrile hydratase, the cluster encodes a GTP cyclohydrolase I, linking the biosynthesis of deazapurines to folate biosynthesis, and a set of purine salvage/biosynthesis genes, which presumably convert the guanine moiety from GTP to the adenine-like deazapurine base found in toyocamycin and sangivamycin. The gene cluster presented here could potentially serve as a model to allow identification of deazapurine biosynthetic pathways in other bacterial species.
We also recommend Trading Suppliers and Manufacturers of SANGIVAMYCIN (cas 18417-89-5). Pls Click Website Link as below: cas 18417-89-5 suppliers
Prev:SANGIVAMYCIN (cas 18417-89-5) induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells
Next:Synthesis of 2′-β-C-methyl toyocamycin and SANGIVAMYCIN (cas 18417-89-5) analogues as potential HCV inhibitors) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Antiviral activities of 2′-deoxyribofuranosyl and arabinofuranosyl analogs of SANGIVAMYCIN (cas 18417-89-5) against retro- and DNA viruses09/07/2019
- Effect of SANGIVAMYCIN (cas 18417-89-5) and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro09/06/2019
- Comparison between the inhibitory activities of SANGIVAMYCIN (cas 18417-89-5) and thioSANGIVAMYCIN (cas 18417-89-5) on nuclear ribonucleic acid synthesis in L1210 cells in vitro09/05/2019
- Design, synthesis and activity against human cytomegalovirus of non-phosphorylatable analogs of toyocamycin, SANGIVAMYCIN (cas 18417-89-5) and thioSANGIVAMYCIN (cas 18417-89-5)☆09/04/2019
- In vivo and enzymatic conversion of toyocamycin to SANGIVAMYCIN (cas 18417-89-5) by Streptomyces rimosus☆09/03/2019
- X-ray crystal structure of SANGIVAMYCIN (cas 18417-89-5), a potent inhibitor of protein kinases09/02/2019
- Synthesis of 2′-β-C-methyl toyocamycin and SANGIVAMYCIN (cas 18417-89-5) analogues as potential HCV inhibitors09/01/2019
- SANGIVAMYCIN (cas 18417-89-5) induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells08/30/2019


